Skip to main content
NeuroWiki

Boston Criteria 2.0 for Cerebral Amyloid Angiopathy Calculator

Age

≥50 required for probable/possible CAA.

Pathology (if available)

Qualifying presentation

Spontaneous ICH, transient focal neurological episodes (TFNE), or cognitive impairment/dementia.

Strictly lobar hemorrhagic lesions (T2*)

ICH, microbleeds, cortical superficial siderosis, or convexity SAH; multiple foci count as multiple. Cerebellar not counted as lobar or deep.

White matter feature

Severe centrum semiovale perivascular spaces (>20 in one hemisphere) OR multispot WMH (>10 subcortical FLAIR dots bilaterally).

Deep hemorrhagic lesions on T2*

Basal ganglia, thalamus, brainstem, deep white matter. Absence required for probable/possible CAA (improves specificity); ~15% of pathologically proven CAA can have deep microbleeds.

Other cause of hemorrhagic lesions

Head trauma, hemorrhagic transformation of ischemic stroke, AVM, hemorrhagic tumor, warfarin INR >3, vasculitis. If any present, CAA criteria are excluded.

Charidimou A, Boulouis G, Frosch M et al.. The Boston Criteria Version 2.0 for Cerebral Amyloid Angiopathy: A Multicentre, Retrospective, MRI–neuropathology Diagnostic Accuracy Study. Lancet Neurol. 2022;21(8):714-725. DOI

Educational use only. Boston Criteria 2.0 require T2*-weighted MRI. Probable/definite CAA significantly increases ICH recurrence risk; anticoagulation decision remains shared decision-making.

Related: HAS-BLED (bleeding risk); ICH Score (mortality).

NeuroWiki is a clinical reference. It does not substitute for your clinical judgment, current guidelines, or your institution's protocol. Verify before acting. Do not enter patient names, MRNs, or dates of birth. Privacy Policy